CANNABIDIOL

Creso enters the growing CBD market in sport and recreation

Finfeed Archived Mar 09, 2021

Today, Creso Pharma Limited (ASX:CPH, FRA:1X8) announced a Letter of Interest (LOI) which marks its entry into the CBD market for sport and recreation; an industry whose global valuation is estimated at US$22Bn by 2022 and C$220m in Canada alone.

Creso Pharma's Mernova enters Canada’s largest recreational cannabis market

Finfeed Archived Feb 17, 2021

Creso Pharma Limited (ASX:CPH, FRA:1X8) has announced that its wholly-owned Canadian subsidiary Mernova Medicinal Inc. has secured four purchase orders (“PO”) for its leading Ritual Green product range, with a total value of C$494,131 (A$502,199).

Creso Pharma set to benefit from OTC cannabidiol sales in Australia

Finfeed Archived Feb 01, 2021

Creso Pharma (ASX: CPH) is prepared to meet demand as OTC sales of low-dose cannabidiol products start in Australian pharmacies.

Creso Pharma delivers second shipment of cannaQIX® adding $320K to growing revenue base

Finfeed Archived Jan 12, 2021

Creso Pharma has delivered a second shipment of cannaQIX® products to Lupin International subsidiary, Pharma Dynamics

What’s Happening to the CPH Share Price?

Next Investors Dec 02, 2020

Over recent days, Creso Pharma (ASX: CPH) appears to have gained some significant momentum. Momentum includes three new purchase orders for Creso Pharma’s anibidiol® line of animal health products were signed today, to a value of $A$414,000.

Creso Pharma poised to cash in on CBD regulatory changes

Finfeed Archived Nov 30, 2020

Creso Pharma (ASX: CPH) has provided a promising update regarding the regulatory status of cannabidiol (CBD) products in Europe.

Changes to OTC cannabis sales just around the corner

Finfeed Archived Nov 26, 2020

The Therapeutic Goods Administration (TGA) will shortly bring down its final decision regarding a major regulatory change in the distribution of cannabidiol (CBD) products in Australia, which could hellp stocks such as Creso Pharma (ASX: CPH).

Creso Pharma to benefit from OTC cannabis sales in Australia

Finfeed Archived Sep 10, 2020

The TGA has recommended that CBD products be down-scheduled to schedule 3 medicines in Australia, allowing OTC sales, which should benefit Creso Pharma (ASX: CPH).

Creso Pharma expands presence in Europe as it enters Portugal and Spain

Finfeed Archived Aug 12, 2020

Creso Pharma Limited (ASX: CPH; FRA: 1X8) has signed a commercial agreement with DHS Business Portugal to introduce the group’s products into the Portuguese and Spanish markets, effectively expanding the company’s presence in Europe.

Cannabidiol